{"id":5097,"date":"2024-05-21T17:11:20","date_gmt":"2024-05-21T17:11:20","guid":{"rendered":"https:\/\/stuarttherapeutics.com\/?page_id=5097"},"modified":"2024-05-22T13:55:16","modified_gmt":"2024-05-22T13:55:16","slug":"all-publications","status":"publish","type":"page","link":"https:\/\/stuarttherapeutics.com\/all-publications\/","title":{"rendered":"All Publications"},"content":{"rendered":"

Publications and Media<\/span><\/h4>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>
<\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>
<\/div><\/div><\/div><\/div><\/div>

All Publications<\/span><\/span><\/h3><\/header>
Dec 12, 2023<\/span>A Phase 2 Trial to Test Safety and Efficacy of ST-100, a Unique Collagen Mimetic Peptide Ophthalmic Solution for Dry Eye Disease. Robert O. Baratta, Eric Schlumpf, Brian J. Del Buono, Shawn DeLorey, George Ousler, David J. Calkins. Ophthalmology Science, December 2023.<\/a><\/span><\/span><\/h5><\/header>
<\/div>\n\n\n
\n

\"Collegen
<\/a><\/h4>\n<\/td>\n

\n

\"Binding
<\/a><\/h4>\n<\/td>\n

\n

\"HR
<\/a><\/h4>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>
<\/div>
Dec 4, 2023<\/span>Collagen Mimetic Peptides Promote Repair of MMP-1-Damaged Collagen in the Rodent Sclera and Optic Nerve Head<\/a><\/span><\/span><\/h5><\/header>
<\/div><\/a>
<\/div>
May 1, 2023<\/span>Repairing the Corneal Nerve Bed Using Collagen Mimetic Peptides<\/a><\/span><\/span><\/h5><\/header>
<\/div><\/a>
<\/div>
May 1, 2023<\/span>Second Harmonic Generation Microscopy of Rat Scleral Remodeling by Collagenase and Reparative Collagen Memetic Peptides<\/span><\/span><\/h5><\/header>
<\/div><\/a>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>
AUGUST 31, 2022<\/span>ST-100 Repairs the Corneal Nerve Bed in Dry Eye Patients<\/a><\/span><\/span><\/h5><\/header>

Stuart\u2019s ST-100, which has demonstrated corneal nerve repair and neuroprotection capabilities in pre-clinical studies, achieved a variety of endpoints in its dry eye disease Phase 2 trial, consistent with a first of its kind nerve reparative approach to the disease, and also addressing all of the DEWS II consequences.<\/span><\/p>\n<\/div>

<\/div>
Read More ><\/a><\/span><\/span><\/h6><\/header><\/div><\/div><\/div>
<\/div>
\"Dry<\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>
JUNE 23, 2022<\/span>Collagen Mimetic Peptides Promote Adherence and Migration of ARPE-19 Cells While Reducing Inflammatory and Oxidative Stress<\/a><\/span><\/span><\/h5><\/header>

Epithelial cells of multiple types produce and interact with the extracellular matrix to maintain structural integrity and promote healthy function within diverse endogenous tissues. Collagen is a critical component of the matrix, and challenges to collagen\u2019s stability in aging, disease,and injury influence survival of adherent epithelial cells…<\/span><\/p>\n<\/div>

<\/div>
Read More ><\/a><\/span><\/span><\/h6><\/header><\/div><\/div><\/div>
<\/div>
\"APRE<\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>
APRIL 21, 2022<\/span>Professor Korok Ray, the Director of the Texas A&M Mays School of Business Innovation Research Center, interviews Stuart Therapeutics\u2019 CEO, Eric Schlumpf on his innovation experiences over a 4 decade career in multiple industries, including drug development.<\/a><\/span><\/span><\/h5><\/header>
<\/div>
Watch VIdeo ><\/a><\/span><\/span><\/h6><\/header>
<\/div>
\"Intraocular<\/a><\/div><\/div><\/div><\/div>
<\/div>